The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTekCapital Regulatory News (TEK)

Share Price Information for TekCapital (TEK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.00
Bid: 7.80
Ask: 8.20
Change: -0.15 (-1.84%)
Spread: 0.40 (5.128%)
Open: 8.15
High: 8.15
Low: 8.00
Prev. Close: 8.15
TEK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Director

7 Jan 2020 07:00

RNS Number : 9112Y
Tekcapital plc
07 January 2020
 

 

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR"). With the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.

 

 

Tekcapital Plc

("Tekcapital", the "Company" or "the Group")

Board Addition

 

THE RT HON LORD WILLETTS FRS JOINS TEKCAPITAL'S BOARD

 

Tekcapital Plc (AIM: TEK), the UK intellectual property (IP) investment group focused on creating marketplace value from investing in university technology, is pleased to announce that Lord David Willetts has joined the Board of Tekcapital with immediate effect.

 

The Rt Hon Lord Willetts FRS is President of the Resolution Foundation and former U.K. Minister for Universities and Science. He served as the Member of Parliament for Havant (1992-2015), and previously worked at HM Treasury and the No. 10 Policy Unit. Lord Willetts is a visiting Professor at King's College London, former Chair of the British Science Association and a member of the Council of the Institute for Fiscal Studies. He is also an Honorary Fellow of Nuffield College, Oxford. Lord Willetts has written widely on economic and social policy. His book 'The Pinch', which focused on intergenerational equity, was published in 2010, and he recently published 'A University Education'. Lord Willetts is a graduate of Oxford University and has been awarded numerous honorary doctorates.

 

Dr Clifford Gross, Executive Chairman at Tekcapital, commented: "We are very pleased to have Lord David Willetts join our board and believe that his extensive business and university experience, coupled with his knowledge regarding the commercialisation of scientific discoveries, will further enhance the board's skills and growth prospects for the Company."

 

The Rt Hon Lord Willetts said "Tekcapital is an exciting company with a global university network. I look forward to helping Tekcapital turn their ideas into the businesses of the future."

 

 

The following information regarding the appointment of Lord David Lindsay Willetts, aged 63, is disclosed under Schedule 2(g) of the AIM Rules for Companies:

 

Current directorships and/or partnerships:

Former directorships and/or partnerships (within the last five years):

 

8GT Advisory Limited

Biotech Growth Trust Plc

Booker Prize Foundation

Davco Limited

Eight Great Technologies Fund

Foundation for Science and Technology

Marchmount Executive Services Limited

Resolution Foundation

Sirius Constellation Limitied

Surrey Satellite Technology Ltd.

Thames Holdings Limited

UK Research and Innovation

Verditek Plc

Borough of Havant Sport and Leisure Trust

British Science Association

Genome Research Ltd and Sanger Institute

National Council for Universities and Business

Science Museum

The Biotech Industry Association

The Council For Industry and Higher Education

The Francis Crick Institute Limited

Vantix Diagnostics Inc.

 

 

Lord Willetts does not have any beneficial interest in the ordinary shares of the Company, but has been granted 100,000 stock options under the Company's stock option plan.

 

There are no further disclosures required under Schedule 2(g) of the AIM Rules for Companies.

 

About Tekcapital plc

Tekcapital creates value from investing in new, university-developed intellectual properties and provides a range of IP investment services to make it easy for organisations to commercialise university-developed technology. Tekcapital is quoted on the AIM market of the London Stock Exchange (AIM: symbol TEK) and is headquartered in Oxford, in the UK. For more information, please visit www.tekcapital.com

LEI: 213800GOJTOV19FIFZ85

For further information, please contact:

Tekcapital Plc 

 

+1 305-200-3450

Clifford M. Gross, Ph.D. 

 

 

 

 

 

SP Angel  Corporate Finance LLP

(Nominated Adviser and Joint Broker)

 

+44 (0) 20 3470 0470 

Richard Morrison / Charlie Bouverat (Corporate Finance)

 

 

 

 

Novum Securities Limited (Joint Broker) 

 

 

 

+44 (0) 20 7399 9427

Colin Rowbury (Corporate Broking) 

 

 

 

Flagstaff Strategic and Investor Communications +44 (0)207 129 1474

Tim Thompson/Andrea Seymour/Fergus Mellon

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAUPUCPGUPUGRQ
Date   Source Headline
2nd Oct 20187:01 amRNSGuident Ltd Appoints Chairman
2nd Oct 20187:00 amRNSPlacing to raise approximately $1.15million
17th Sep 20187:00 amRNSBelluscura PLC Expands its Patent Portfolio
7th Sep 20187:00 amRNSAppointment of Joint Broker
21st Aug 20182:04 pmRNSHolding(s) in Company
14th Aug 20187:00 amRNSHalf-year Report
6th Aug 20187:00 amRNSMarketing & Technology Transfer Hub
3rd Aug 20187:00 amRNSLucyd Pte Ltd. Launches eShop
1st Aug 20187:00 amRNSSalarius Ltd Appoints CEO
4th Jul 20187:00 amRNSLucyd Pte Ltd. Update
29th Jun 20187:00 amRNSChange of Adviser
30th May 201812:53 pmRNSResult of Annual General Meeting
29th May 20187:00 amRNSHolding(s) in Company
22nd May 20187:00 amRNSLucyd Appoints Global Marketing Manager
22nd May 20187:00 amRNSSalarius Ltd Appoints Directors
17th May 20187:00 amRNSPrivate Placement for Belluscura plc
15th May 20181:17 pmRNSHolding(s) in Company
10th May 20187:00 amRNSHolding(s) in Company
8th May 20187:00 amRNSUniversity Technology Commercialization Programme
4th May 20181:45 pmRNSFinal Results
19th Apr 20187:00 amRNSUK Investor Show
1st Mar 20187:00 amRNSUpdate on Lucyd Blockchain Token Generation Event
14th Feb 20187:00 amRNSPrivate Placement for Belluscura to raise US$1.33m
24th Jan 20187:00 amRNSHolding(s) in Company
22nd Jan 20187:00 amRNSUpdate on Lucyd Blockchain Token Generation Event
18th Dec 20174:14 pmRNSHolding(s) in Company
1st Dec 201710:14 amRNSUpdate re. Belluscura IPO
16th Nov 20178:00 amRNSUpdate re. Belluscura IPO
30th Oct 20177:00 amRNSAcquisition of a Patented AI Valet System
28th Sep 20177:00 amRNSPortfolio Company to Raise Funds via a Token Sale
22nd Sep 20177:00 amRNSInvestor Briefing
31st Jul 20177:00 amRNSHalf-year Report
31st May 201711:18 amRNSResult of AGM
31st May 20177:00 amRNSAcquisition of New Gesture Recognition Technology
9th May 20175:13 pmRNSFinal Results
8th May 20179:11 amRNSNotice of AGM
3rd May 20177:00 amRNSPrivate Placement for Belluscura Ltd
2nd May 20179:31 amRNSApp to Search Global University IP
25th Apr 20177:00 amRNSBelluscura acquires Nanotether Discovery Science
20th Mar 20179:11 amRNSHolding(s) in Company
16th Mar 20179:30 amRNSHolding(s) in Company
10th Mar 20179:31 amRNSExercise of Warrants
3rd Mar 20177:00 amRNSBelluscura Launches Passport Medical Device in US
2nd Mar 20177:00 amRNSBelluscura Ltd Launches Slyde in EU
1st Mar 20177:00 amRNSBelluscura Ltd Launches Wire CaddyT In USA
28th Feb 20177:00 amRNSLicense and Development Agreement
15th Feb 20177:00 amRNSAppointment of Joint Broker
2nd Feb 20179:55 amRNSHolding(s) in Company
1st Feb 20175:25 pmRNSHolding(s) in Company
31st Jan 20174:26 pmRNSTotal Voting Rights and Holding in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.